Changchun High-Tech Industry (Group) Co., Ltd. (SHE: 000661)

Market Cap	44.35B
Revenue (ttm)	14.27B
Net Income (ttm)	3.71B
Shares Out	402.05M
EPS (ttm)	9.04
PE Ratio	12.20
Forward PE	9.37
Dividend	4.50 (4.02%)
Ex-Dividend Date	n/a

Volume	5,827,774
Open	117.20
Previous Close	111.98
Day's Range	110.25 - 117.20
52-Week Range	77.50 - 165.73
Beta	0.50
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 22, 2024

About Changchun High-Tech Industry (Group)

Changchun High-Tech Industry (Group) Co., Ltd., together with its subsidiaries, researches, develops, manufactures, and sells biopharmaceuticals and traditional Chinese medicines products in China. The company offers genetic engineering pharmaceuticals, biological vaccines, modern Chinese medicines, and other pharmaceutical products; and antibody and other chemical drugs. It also develops real estate properties. Changchun High-Tech Industry (Group) Co., Ltd. was founded in 1993 and is based in Changchun, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1993
• Employees: 9,029
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000661

Financial Performance

In 2023, Changchun High-Tech Industry (Group)'s revenue was 14.57 billion, an increase of 15.35% compared to the previous year's 12.63 billion. Earnings were 4.53 billion, an increase of 9.47%.